This patient has been diagnosed with melanoma, which appears to be stage IIC. The 5-and 10-year survival rates for postsurgical stage IIC melanoma are poor (45.1% and 32.3%, respectively). 1 While the evidence for complementary therapies is not definitive, there is a reasonable basis of support. Since there are few, if any, side effects associated with these approaches, there is potentially much to gain and little to lose by incorporating those treatments with the best literature support.
My goal is to use those elements of diet, lifestyle modification, nutrient supplementation, and herbal medicine that have the strongest scientific support for antimelanoma activity.
There are a variety of naturopathic therapies with varying degrees of evidence of benefit for melanoma patients. Mistletoe extract and melatonin are supported by human clinical trials, and other elements rely on in vitro, in vivo, and epidemiological data alone. While any single intervention may have only a small effect on recurrence and survival, it seems reasonable that several changes together could provide substantial benefit.
Diet, Lifestyle, Environment, and Melanoma
The suggestions I offer cancer patients vary according to the type of cancer and their current health and treatment status. Rather than review the benefits of a whole foods diet, I have limited myself to a discussion of those things that I consider essential to the case at hand.
Reducing or Eliminating Refined Sugars, Including Fruit Juices
There is a clear association between elevated dietary sugar intake and cancer in general. As serum glucose rises, so does insulin production. The connection between increased insulin levels and cancer is well known. 2 Several studies have found increased tumor formation in both animals and humans consuming diets high in refined sugars. [3] [4] [5] A recent large cohort study of 1.3 million people found a strong association between increased fasting glucose levels and several major cancers. 6 Elevated glucose levels suppressed the activity of peripheral blood mononuclear cells from healthy individuals. 7 My goal is to make the patient aware of the issue and work with them at making changes. Some patients make small changes, and other make more significant ones. The patient in this case has already made this change, and I would thus reinforce his decision.
Reduce the Consumption of Polyunsaturated Fatty Acids
Some studies have found a significantly increased risk for melanoma associated with diets high in polyunsaturated fatty acids (PUFA), [8] [9] [10] while others have not. 11, 12 The adipose tissue of melanoma patients has been found to contain significantly higher amounts of PUFA than that of controls. 9 When mice were inoculated with melanoma cells, those consuming diets high in PUFA formed tumors faster than control mice did. 13 Therefore, I would recommend reducing the intake of most seed oils.
Green Tea
Several in vitro and animal studies demonstrate the activity of green tea catechins against both human and animal melanoma cells. [14] [15] [16] [17] [18] [19] The major catechin in green tea, epigallocatechin gallate (EGCG), appears to have the most powerful anticancer properties. In one study, animals were injected with highly invasive melanoma cells. Oral administration of EGCG (0.05 or 0.1% per drinking water) significantly reduced the number and size of lung tumors, compared with controls. 19 I recommend that the patient drink green tea freely each day or supplement with 1 to 2 capsules of a standardized extract.
Ground Flaxseeds
Ground flaxseeds are best known for their benefits in breast and prostate cancers. A number of biological properties of flax lignans are believed to be associated with their anticancer effects. These include favorable effects on hormone metabolism, 20 aromatase inhibition, 21 angiogenesis inhibition, 22 and antiproliferative effects. 23 Research suggests advantages for melanoma as well; however, the mechanism for these effects has not been established. Animals injected with melanoma cells formed fewer and smaller tumors when fed flaxseed. Lung metastases were also significantly reduced. 24, 25 I would recommend 1 to 3 tablespoons of ground flaxseeds daily.
Alcohol
There are conflicting reports on alcohol consumption as a risk factor for melanoma. Several studies have found no association, [26] [27] [28] [29] while others report a significant risk, [30] [31] [32] [33] including a recent well-controlled study with a large number of cases. 30 Further concern comes from animal studies showing immune suppression and increased melanoma metastases with alcohol consumption. [34] [35] [36] It would seem prudent for high-risk melanoma patients to avoid alcohol until more definitive research is complete.
Exercise
There is evidence that exercise and/or maintaining a normal body mass index may decrease the risk of melanoma. In a large cohort of 4.5 million men, obesity was significantly associated with the risk of melanoma. 37 Other studies have found similar associations. 38, 39 A study looking at exercise and melanoma risk found that men and women exercising 5 to 7 times a week had a 30% decreased risk of developing melanoma. 38 I would recommend that the patient work toward increasing the intensity and duration of his exercise.
Toxic Metals
There are several reports suggesting a causal relationship between arsenic exposure and nonmelanoma skin cancers, 40 and a clustering of melanoma cases has been reported in areas of elevated environmental dis-tributions of arsenic. 41 While a clear relationship between toxic metal exposure and melanoma has not been established, I believe it is a reasonable and important area to explore. Most toxic metals are known carcinogens, [42] [43] [44] [45] and experimental evidence shows that some (particularly arsenic and nickel) increase the growth and progression of melanoma in animal models. [46] [47] [48] [49] To assess tissue stores of toxic metals, I would recommend a provocative toxic metal urinalysis using dimercaptosuccinic acid to determine if any chelation is necessary.
Adjuvant Therapies
Melatonin Melatonin significantly inhibits the growth of human and animal melanoma cell lines in vitro and in vivo. [50] [51] [52] [53] [54] [55] Melatonin production is much lower in melanoma patients than healthy controls. 56 In patients with advanced melanoma, melatonin significantly enhanced the effectiveness of the combination of low-dose interleukin-2 and cisplatin. 57 Metastatic melanoma patients treated with high doses of melatonin alone showed an objective tumor response of 15%. 58 Melanoma patients were randomized after surgical treatment for lymph node recurrence to receive 20 mg of melatonin nightly or no treatment. After a median follow-up of 2.6 years, disease-free survival was significantly higher in the melatonin group (71% vs 31%). 59 While the clinical trials were small, the evidence for melatonin's activity against melanoma is some of the strongest and most compelling among integrative approaches. In addition, melatonin should benefit this patient's insomnia and anxiety. 59 
Mistletoe Extract
There are 2 controlled clinical trials assessing the efficacy of the fermented mistletoe extract (FME) Iscador, among postsurgical stage II and III melanoma patients. The first published trial was a prospective, randomized phase III adjuvant trial (RCT) evaluating the efficacy and toxicity of low-dose recombinant interferon-α2b, recombinant interferon-γ, FME, or control. The patients were treated for 1 year and followed over 8 years until progression or death. None of the treatment groups showed any improvements in survival. 60 However, a multicenter, retrolective cohort study assessed the effectiveness of FME or watchful waiting in 686 melanoma patients. Treatment took place for a median duration of 2.5 years. Significant improvements in tumor-related mortality (hazard ration [HR] = 0.41), overall survival (HR = 0.64), disease-free survival (HR = 0.73), and brain metastasis (HR = 0.33) were found for FME treatment in comparison with the control group. 61 The retrolective cohort study used meticulous design and control methods, which lends significant weight to the findings. The disparity in outcomes between the trials may well be explained by important differences in design.
The RCT consisted of more than 50% stage III patients compared with 5% to 8% in the cohort study. Median therapy duration was 2.5 years in the cohort study and 1 year or less in the RCT. The RCT used the specific extract Iscador Mali, while most subjects in the cohort trial used Iscador Pini. The latter is the form recommended by the manufacturer for melanoma cases. Last, the FME group was relatively small in the RCT. An insufficient test power at 5 years and later is possible, while the test power of the cohort study was greater than 80% for more than 5 years of follow-up. 61 The results of the cohort trial show significant benefit and are more reliable than the RCT. In addition, FME is well tolerated and affordable. Therefore, I would recommend treatment with Iscador Pini.
Vitamin E Succinate
There are a number of cell culture and animal studies that suggest potential benefits for vitamin E supplementation in melanoma patients. [62] [63] [64] [65] [66] [67] [68] Most of these studies found antimelanoma activity using the succinate form of vitamin E (VES). For example, when athymic mice were inoculated with melanoma cells and treated with VES, it profoundly inhibited tumor growth 10-fold. Even when VES treatment began after tumor formation, there was significant tumor growth inhibition. 63 I would ensure that the patient is taking the succinate form and increase his dose to 800 to 1200 IU daily.
Selenium
Selenomethionine dose dependently inhibits the growth of human melanoma cells without effecting healthy cells. 69 Several studies have also shown inhibitory effects on melanoma growth and spread in animals using low doses. [70] [71] [72] [73] Melanoma patients have significantly lower serum selenium levels than do healthy controls, and the decrease relates directly to the severity of their disease and rate of recurrence. 74, 75 I would recommend 200 to 400 µg/d of selenomethionine.
Vitamin D A significant reduction in the risk of melanoma (odds ratio = 0.59) is found in those with the highest dietary intake of vitamin D compared with those with the lowest intake. 76 Melanoma cell lines express vitamin D re-ceptors (VDR) to varying degrees. In both animal 77, 78 and human [79] [80] [81] [82] melanoma cells that express VDR, the antiproliferative and differentiating effects of 1,25(OH)2D3 are significant. When mice were inoculated with melanoma cells, pulmonary metastases were inhibited in mice treated with active vitamin D. 83 In mice with human melanoma xenographs, active vitamin D at pharmacological dosages was shown to significantly suppress tumor growth. 84 In addition, it is probable that most melanoma patients will reduce their sun exposure and thereby decrease their levels of vitamin D. For that reason alone, supplementation seems prudent. I recommend 800 to 1200 IU daily. Toxicity has been shown only using doses many times greater. 85 
Genistein
Genistein is one of the major isoflavones found in soybeans. It inhibits tyrosine kinase and topoisomerase II, which may explain some of its effects on a number of different cancers. Genistein significantly inhibits melanoma growth and metastasis. [86] [87] [88] [89] [90] [91] In mice inoculated with melanoma, lung metastases were reduced by 53.6%, and life span increased by 47% in genistein-fed animals compared with controls. 91 Chemotherapy has little ability to induce differentiation in melanoma cells. Uniquely, genistein has been found to induce cell differentiation in a number of studies. [87] [88] [89] [90] [91] [92] [93] [94] It significantly enhances cisplatin-induced apoptosis of melanoma cells 9 5 and inhibits angiogenesis alone or in combination with cyclophosphamide. 96 Importantly, many of the studies used dosages similar to those reported in humans consuming high-soy diets. 87, 95, 97 I would recommend 100 to 200 mg of soy isoflavones daily.
Further Considerations
Other elements worthy of consideration but beyond the limit of this review include curcumin, vitamin A, thymus extracts, the restriction of phenylalanine and tyrosine in the diet, the Gerson Method, and guided visualization.
While more research of integrative therapies is desperately needed, there currently exists within the scientific and medical literature a plethora of information with varying degrees of support for these approaches. With few good options and unsatisfactory odds for high-risk melanoma patients, evidence-based complementary approaches can offer substantial hope and benefit.
